Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Transplantation. 2015 Dec;99(12):2494–2503. doi: 10.1097/TP.0000000000000830

Figure 3. EVLP-directed delivery of ATL1223 reduces proinflammatory cytokine production in DCD lungs.

Figure 3

Compared to lungs after cold static preservation (CSP), expression of CXCL1, CCL2 and TNF-α were slightly, but not significantly, reduced by EVLP. ATL1223 treatment during EVLP resulted in significant reductions in expression of CXCL1, CCL2 and TNFα. One-way ANOVA with post-hoc Tukey's multiple comparison test was performed to compare groups. Results are presented as mean ± SEM. *p<0.05 versus CSP; #p<0.05 versus EVLP; n=4-7/group.